var data={"title":"Secondary (late) postpartum hemorrhage","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Secondary (late) postpartum hemorrhage</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Michael A Belfort, MBBCH, MD, PhD, FRCSC, FRCOG</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Lynn L Simpson, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Deborah Levine, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Vanessa A Barss, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H908497887\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postpartum hemorrhage (PPH) may occur shortly after delivery or, less commonly, days later. This topic will discuss secondary (also called late) PPH. Issues related to primary or early PPH are reviewed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">&quot;Overview of postpartum hemorrhage&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=postpartum-hemorrhage-medical-and-minimally-invasive-management\" class=\"medical medical_review\">&quot;Postpartum hemorrhage: Medical and minimally invasive management&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=postpartum-hemorrhage-management-approaches-requiring-laparotomy\" class=\"medical medical_review\">&quot;Postpartum hemorrhage: Management approaches requiring laparotomy&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1030069322\"><span class=\"h1\">DEFINITION/DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Secondary (also called late) PPH is generally defined as any significant uterine bleeding occurring between 24 hours and 12 weeks postpartum [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/1,2\" class=\"abstract_t\">1,2</a>]. However, definitions vary (eg, between 48 hours and 6 weeks postpartum).</p><p class=\"headingAnchor\" id=\"H3833543019\"><span class=\"h1\">INCIDENCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Secondary PPH occurs in 0.2 to 2 percent of postpartum women in high-income countries [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2-5\" class=\"abstract_t\">2-5</a>]. Most studies report peak incidence is at one to two weeks postpartum [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H1888908394\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common causes of secondary PPH are [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retained products of conception</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Subinvolution of the placental bed, <span class=\"nowrap\">and/or</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infection</p><p/><p>Rare causes include [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2,6-16\" class=\"abstract_t\">2,6-16</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inherited or acquired bleeding diatheses</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pseudoaneurysm of the uterine artery</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arteriovenous malformations</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Choriocarcinoma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Undiagnosed carcinoma of the cervix</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adenomyosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infected polyp or submucosal fibroid</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Uterine diverticulum </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Excessive bleeding with resumption of menses </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypoestrogenism</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dehiscence of a cesarean scar</p><p/><p>Sometimes the cause cannot be determined.</p><p class=\"headingAnchor\" id=\"H3270025581\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A previous history of secondary PPH appears to predispose to a recurrence, as with primary PPH [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/17-19\" class=\"abstract_t\">17-19</a>]. A history of primary PPH is a risk factor for severe secondary PPH [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/4,19,20\" class=\"abstract_t\">4,19,20</a>].</p><p class=\"headingAnchor\" id=\"H3152310892\"><span class=\"h1\">CLINICAL PRESENTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vaginal bleeding in excess of what is expected is the presenting symptom in all patients. Bleeding may be accompanied by pelvic pain, fever, <span class=\"nowrap\">and/or</span> uterine tenderness. These clinical findings are nonspecific; moreover, it is normal to have some postpartum bleeding and discomfort. (See <a href=\"topic.htm?path=overview-of-the-postpartum-period-physiology-complications-and-maternal-care#H5\" class=\"medical medical_review\">&quot;Overview of the postpartum period: Physiology, complications, and maternal care&quot;, section on 'Uterine involution'</a>.)</p><p class=\"headingAnchor\" id=\"H329570042\"><span class=\"h1\">STABILIZATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For the patient who has heavy bleeding and is hemodynamically unstable, stabilization with fluids and transfusion of blood products is the priority (<a href=\"image.htm?imageKey=OBGYN%2F101276\" class=\"graphic graphic_algorithm graphicRef101276 \">algorithm 1</a>), followed by diagnostic evaluation. </p><p>In women experiencing secondary PPH in the first few weeks after delivery, the uterine cavity may be large enough to admit a balloon tamponade device, which may be useful to limit bleeding while diagnostic evaluation occurs. If the fundus is not palpable abdominally, the uterine cavity is probably too small to accommodate a commercial uterine tamponade device, but it may still be possible to place a standard bladder catheter with a 10 to 30 mL balloon into the uterine cavity and use this balloon for tamponade. If neither is available, packing the uterus with gauze may limit hemorrhage while the patient is brought to a location for definitive therapy.</p><p>If the patient cannot be stabilized promptly, she should be transferred to a venue suitable for emergency surgical intervention (operating room or hybrid suite), where examination under anesthesia and surgical procedures for control of hemorrhage can be performed. (See <a href=\"topic.htm?path=postpartum-hemorrhage-management-approaches-requiring-laparotomy\" class=\"medical medical_review\">&quot;Postpartum hemorrhage: Management approaches requiring laparotomy&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H1803423708\"><span class=\"h1\">DIAGNOSTIC EVALUATION</span></p><p class=\"headingAnchor\" id=\"H1067536136\"><span class=\"h2\">History and physical examination</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>What is the past obstetric history (including the recent delivery)? If the patient had a previous PPH, recurrent PPH may have the same etiology. Did the most recent pregnancy have risk factors for retained products of conception (eg, preterm delivery, multiple gestation, retained placenta) or postpartum endometritis? (See <a href=\"topic.htm?path=postpartum-endometritis#H3\" class=\"medical medical_review\">&quot;Postpartum endometritis&quot;, section on 'Risk factors'</a>.)</p><p/><p class=\"bulletIndent1\">What was the route of delivery? Retained products of conception are much more likely after vaginal delivery than cesarean delivery, whereas postpartum endometritis is more likely after cesarean.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Does the patient have risk factors for a bleeding diathesis, such as von Willebrand disease (VWD). A history of menorrhagia or other personal or family history of excessive or unusual bleeding increases the probability of a bleeding diathesis. In one study of 16 deliveries of women with unrecognized VWD, the incidence of primary and secondary PPH was 47 and 31 percent, respectively [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/21\" class=\"abstract_t\">21</a>].</p><p/><p class=\"bulletIndent1\">Basic laboratory screening for a bleeding diathesis includes platelet count, prothrombin time, and activated partial thromboplastin time; however, these tests may be normal in women with von Willebrand disease. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H11\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'Laboratory testing'</a> and <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H22\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'Diagnostic approach'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Is the patient taking any medications (prescribed, over-the-counter, diet supplements, or vitamins) that may predispose her to uterine bleeding, such as anticoagulants, platelet inhibitors, and uterine relaxants?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Has the patient had vaginal penetration since delivery that may have caused trauma or increased the risk for uterine infection (tampon, finger, other foreign object [intrauterine device], vaginal intercourse)?</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Are signs or symptoms of uterine infection present, such as uterine pain or tenderness, fever, tachycardia, or malodorous vaginal discharge? (See <a href=\"topic.htm?path=postpartum-endometritis\" class=\"medical medical_review\">&quot;Postpartum endometritis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2114630160\"><span class=\"h2\">Imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ultrasound examination (including color and spectral flow Doppler) of the uterus may detect the cause of bleeding and will help exclude some potential bleeding sources in the differential diagnosis. However, the postpartum uterus has a variable appearance on ultrasound examination, and there is considerable overlap between normal postpartum findings (<a href=\"image.htm?imageKey=OBGYN%2F73717\" class=\"graphic graphic_diagnosticimage graphicRef73717 \">image 1</a>) and findings associated with secondary bleeding [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/22,23\" class=\"abstract_t\">22,23</a>]. In both cases, the uterus may be empty or contain gas, fluid, or echogenic material.</p><p class=\"headingAnchor\" id=\"H299044673\"><span class=\"h3\">Findings</span></p><p class=\"headingAnchor\" id=\"H63300053\"><span class=\"h4\">Endometritis and intrauterine infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ultrasound findings are often nonspecific in endometritis (<a href=\"image.htm?imageKey=OBGYN%2F101346\" class=\"graphic graphic_diagnosticimage graphicRef101346 \">image 2</a>). The uterus may have a thickened, heterogenous endometrium or show common normal postpartum findings, such as intracavitary debris, fluid, or gas. Infected retained placental <span class=\"nowrap\">tissue/fetal</span> membranes or a hematoma may also be present.</p><p class=\"headingAnchor\" id=\"H4267008826\"><span class=\"h4\">Retained products of conception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vascularity of echogenic intracavitary material is a key finding as vascularity on color Doppler suggests retained products (<a href=\"image.htm?imageKey=OBGYN%2F101344%7EOBGYN%2F101347\" class=\"graphic graphic_diagnosticimage graphicRef101344 graphicRef101347 \">image 3A-B</a>) whereas lack of vascularity is consistent with blood clot (<a href=\"image.htm?imageKey=OBGYN%2F101345\" class=\"graphic graphic_diagnosticimage graphicRef101345 \">image 4</a>), but does not exclude the presence of retained necrotic (avascular) placental tissue. If no intracavitary mass, endometrial fluid, or vascularity is seen and the endometrial thickness is thin, retained products are not likely.</p><p>Retained products of conception have a variable and sometimes nonspecific appearance on ultrasound. They often appear as a solid, echogenic intracavitary mass that extends to the endometrium. However, necrotic decidua and blood clots can mimic retained placental fragments. Color and spectral Doppler showing high-velocity, low-resistance arterial flow in the mass differentiates placental tissue from hematoma, but is not always present in the retained tissue. In the absence of a mass, increased vascularity in a thickened postpartum endometrium is also consistent with retained placental tissue. Rarely, a focal morbidly adherent placenta presents as secondary postpartum hemorrhage. Ultrasound findings include a mass that extends into or beyond the myometrium. (See <a href=\"topic.htm?path=overview-of-the-postpartum-period-physiology-complications-and-maternal-care#H1200898081\" class=\"medical medical_review\">&quot;Overview of the postpartum period: Physiology, complications, and maternal care&quot;, section on 'Findings on ultrasound'</a>.)</p><p class=\"headingAnchor\" id=\"H2144156391\"><span class=\"h4\">Subinvolution of the placental site</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subinvolution of the placental site may be suspected when hypoechoic tortuous vessels are seen along the inner third of the myometrium [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/24\" class=\"abstract_t\">24</a>]. Pulsed wave Doppler sonography shows increased peak systolic velocity (PSV) (&gt;0.83 <span class=\"nowrap\">m/s;</span> normal 0.22 <span class=\"nowrap\">m/s</span> three days postpartum, falling to 0.10 <span class=\"nowrap\">m/s</span> after six weeks) with a low-resistance waveform along the inner third of the myometrium. The increased areas of vascularity correlate with the placental implantation site documented by predelivery sonography. However, these findings cannot always be differentiated from congenital or acquired arteriovenous malformations, and retained products of conception may mimic these findings when echogenic tissue is present within the endometrial cavity.</p><p class=\"headingAnchor\" id=\"H2834089873\"><span class=\"h4\">Bleeding diathesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both bleeding diathesis and subinvolution can be associated with intracavitary hematomas, which can mimic the ultrasound appearance of retained products of conception. Doppler ultrasound helps to distinguish among these disorders. Hematomas are not vascularized, whereas retained placental tissue may have vascular flow within the mass on Doppler. Women with subinvolution and an intracavitary hematoma may have increased peak systolic velocity (PSV) and low-resistance arterial flow within the myometrium at the placental implantation site but not in the mass, and the uterus may be enlarged.</p><p class=\"headingAnchor\" id=\"H2786060684\"><span class=\"h4\">Vascular malformations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Arteriovenous malformation (AVM) and pseudoaneurysm have characteristic features on ultrasound. Ultrasound findings of an AVM include multiple hypoechoic or anechoic serpentine spaces within the myometrium, with turbulent flow on color Doppler and high-velocity and low-resistance flow on spectral analysis. A PSV &gt;0.83 <span class=\"nowrap\">m/s</span> in&nbsp;vascular malformations has been associated with a high risk of hemorrhage, while PSV &lt;0.83 <span class=\"nowrap\">m/s</span> has been associated with at lower risk and PSV &lt;0.39 <span class=\"nowrap\">m/s</span> has been associated with a low risk [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/25\" class=\"abstract_t\">25</a>]. Subtle myometrial heterogeneity, a myometrial or endometrial mass, or prominent parametrial vessels may be observed.</p><p>Ultrasound findings of a uterine artery pseudoaneurysm may include a hypoechoic intrauterine lesion, vascularity on color Doppler, and bidirectional systolic and diastolic flow with aliasing on spectral Doppler.</p><p class=\"headingAnchor\" id=\"H280235462\"><span class=\"h4\">Hypoestrogenism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A normal-appearing uterus with a thin endometrium may be a sign of hypoestrogenism.</p><p class=\"headingAnchor\" id=\"H1611553929\"><span class=\"h2\">Laboratory tests</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete blood count.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prothrombin time, activated partial thromboplastin time, fibrinogen level.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human chorionic gonadotropin &ndash; In women with bleeding many weeks after delivery, a quantitative pregnancy test is useful for evaluating for choriocarcinoma, retained products of conception, or even a new pregnancy. Ultrasound examination and serial determinations of human chorionic gonadotropin may be needed to distinguish among these entities when the test is positive. (See <a href=\"#H2373948967\" class=\"local\">'Management'</a> below.)</p><p/><p class=\"headingAnchor\" id=\"H3751209655\"><span class=\"h2\">Selective testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If the diagnosis is uncertain after the history, physical examination, ultrasound imaging, and laboratory evaluation, then additional testing may be warranted. Laboratory testing that might be ordered in these cases includes: FSH, LH, TSH, estradiol, and progesterone to rule out a possible hypoestrogenic state and to determine the cause.</p><p>Three-dimensional ultrasound examination and saline infusion sonohysterography can be helpful to rule out a structural anomaly not identified on routine two-dimensional ultrasound examination and to identify potential sources of bleeding other than the endometrium (such as a scar dehiscence).</p><p class=\"headingAnchor\" id=\"H2373948967\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H4066198572\"><span class=\"h2\">Management of common causes of secondary PPH</span></p><p class=\"headingAnchor\" id=\"H3495049404\"><span class=\"h3\">Initial approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Our initial approach to management is based on the suspected etiology of bleeding (<a href=\"image.htm?imageKey=OBGYN%2F101276\" class=\"graphic graphic_algorithm graphicRef101276 \">algorithm 1</a>).</p><p>Whether to initially manage secondary PPH medically or surgically is still a relatively unstudied aspect of the care of these patients. No data from randomized trials are available to guide management [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/3\" class=\"abstract_t\">3</a>]. A retrospective study of 168 women with secondary PPH compared the outcomes of those initially managed with surgical evacuation of the uterus with those initially managed medically [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/26\" class=\"abstract_t\">26</a>]. Primary surgical treatment was associated with a higher frequency of negative primary outcomes (blood transfusion, uterine perforation after curettage, use of broad-spectrum antibiotics, hysterectomy) than primary medical treatment (37.5 versus 16.5 percent). Approximately one-quarter of women initially treated medically required secondary surgical evacuation and 15 percent required readmission, whereas 8 percent of those treated surgically had these outcomes. In addition, primary surgical treatment was associated with a trend toward fewer future deliveries and an increased rate of secondary infertility. This study suggests that a conservative medical approach may be superior to primary surgical treatment, but is limited by selection bias.</p><p class=\"headingAnchor\" id=\"H1335192041\"><span class=\"h3\">Retained products of conception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Surgical procedures (dilation and curettage, suction curettage) are directed at evacuation of retained products of conception, which are more common after vaginal than cesarean delivery and when a vascularized endometrial mass is noted on color Doppler.</p><p>Ideally, curettage is performed under ultrasound guidance. This is likely to reduce the rate of perforation, allow identification of placental tissue, and confirm that this tissue has been evacuated [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/22\" class=\"abstract_t\">22</a>]. Suction curettage should be employed when bleeding is over 500 mL and is not controlled by medical measures. The size of the suction cannula is determined by the size of the uterus. The diameter of the cannula is usually chosen according to the uterine size by gestational age (eg, a 12 mm cannula for a uterus of 12 weeks size) with a minimum diameter of 10 mm and a maximum diameter of 16 mm.</p><p>Uterine perforation and formation of intrauterine adhesions are the major complications of surgery. In the series described above, perforation occurred in 3 percent of cases [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"topic.htm?path=intrauterine-adhesions-clinical-manifestation-and-diagnosis\" class=\"medical medical_review\">&quot;Intrauterine adhesions: Clinical manifestation and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H647402319\"><span class=\"h3\">Subinvolution of the placental site</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If subinvolution of the placental site is suspected, uterotonic agents are given. Options include <a href=\"topic.htm?path=methylergonovine-drug-information\" class=\"drug drug_general\">methylergonovine</a> (0.2 mg intramuscularly, repeated every two to four hours up to three doses), or intramuscular <a href=\"topic.htm?path=carboprost-tromethamine-drug-information\" class=\"drug drug_general\">carboprost tromethamine</a> (Hemabate, 250 mcg intramuscularly; up to eight doses at intervals at least 15 minutes apart), <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=oxytocin-drug-information\" class=\"drug drug_general\">oxytocin</a> infusion. These agents will not be useful if the uterus is firm.</p><p>Surgical procedures (dilation and curettage, suction curettage) are often effective when medical management fails, even if retained placental or membrane fragments cannot be identified sonographically [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/4,27\" class=\"abstract_t\">4,27</a>]. As an example, a study of 132 consecutive women with secondary PPH reported 75 (57 percent) were initially treated with surgical evacuation, which was successful in 67 (90 percent) [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/4\" class=\"abstract_t\">4</a>]. Of the 57 women initially managed medically, treatment was successful in 41 (72 percent); 16 women had continuing symptoms, of whom 12 subsequently underwent surgical evacuation. Tissue specimens were obtained at surgery in only 38 women, and just one-third of these had histological confirmation of placental tissue. The histologic diagnosis of placental subinvolution is based on dilated myometrial arteries with hyaline material replacing the medial layer, partial occlusion by thrombi of variable age, and extravillous trophoblast in and around the placental bed vessels [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/28,29\" class=\"abstract_t\">28,29</a>].</p><p>Selective arterial embolization has been effective for controlling severe bleeding in high-risk patients, who can be refractory to uterotonic drugs or uterine curettage [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2,30,31\" class=\"abstract_t\">2,30,31</a>]. If percutaneous therapy fails, hysterectomy may be required.</p><p class=\"headingAnchor\" id=\"H2527119692\"><span class=\"h3\">Endometritis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If bleeding is not massive and fever, uterine tenderness, <span class=\"nowrap\">and/or</span> a malodorous discharge are present, then endometritis should be suspected. Under these circumstances, we prescribe broad-spectrum antibiotic therapy (<a href=\"image.htm?imageKey=OBGYN%2F64669\" class=\"graphic graphic_table graphicRef64669 \">table 1</a>). However, some clinicians administer antibiotics to all patients with secondary PPH, including those without obvious signs of infection. Rare, but potentially lethal causes of endometritis include <em>Clostridium sordellii</em> [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/32-35\" class=\"abstract_t\">32-35</a>], <em>Clostridium perfringens</em> [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/36\" class=\"abstract_t\">36</a>], and streptococcal or staphylococcal toxic shock syndrome [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/37-39\" class=\"abstract_t\">37-39</a>]. (See <a href=\"topic.htm?path=postpartum-endometritis#H116608421\" class=\"medical medical_review\">&quot;Postpartum endometritis&quot;, section on 'Endometritis with toxic shock syndrome'</a>.)</p><p class=\"headingAnchor\" id=\"H929780837\"><span class=\"h2\">Management of uncommon and rare causes of secondary PPH</span></p><p class=\"headingAnchor\" id=\"H2786981985\"><span class=\"h3\">Vascular lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Selective arterial embolization is the preferred approach for women with radiographic diagnosis of a vascular lesion as the source of bleeding [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2,30,40\" class=\"abstract_t\">2,30,40</a>].</p><p class=\"headingAnchor\" id=\"H370424034\"><span class=\"h3\">Bleeding diathesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Women whose history and laboratory results are diagnostic of a bleeding diathesis should be treated as appropriate for the underlying disorder (refer to the relevant topic review for the specific disorder). Consultation with a hematologist is advised.</p><p class=\"headingAnchor\" id=\"H3225548484\"><span class=\"h3\">Neoplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of patients with neoplasia depends on the specific disorder:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gestational trophoblastic disease (<a href=\"image.htm?imageKey=OBGYN%2F75900\" class=\"graphic graphic_diagnosticimage graphicRef75900 \">image 5</a> and <a href=\"image.htm?imageKey=OBGYN%2F52443\" class=\"graphic graphic_diagnosticimage graphicRef52443 \">image 6</a>) (see <a href=\"topic.htm?path=gestational-trophoblastic-neoplasia-epidemiology-clinical-features-diagnosis-staging-and-risk-stratification\" class=\"medical medical_review\">&quot;Gestational trophoblastic neoplasia: Epidemiology, clinical features, diagnosis, staging, and risk stratification&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cervical cancer (see <a href=\"topic.htm?path=invasive-cervical-cancer-epidemiology-risk-factors-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=management-of-early-stage-cervical-cancer\" class=\"medical medical_review\">&quot;Management of early-stage cervical cancer&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endometrial polyp (see <a href=\"topic.htm?path=endometrial-polyps\" class=\"medical medical_review\">&quot;Endometrial polyps&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adenomyosis (see <a href=\"topic.htm?path=uterine-adenomyosis\" class=\"medical medical_review\">&quot;Uterine adenomyosis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fibroid (see <a href=\"topic.htm?path=overview-of-treatment-of-uterine-leiomyomas-fibroids\" class=\"medical medical_review\">&quot;Overview of treatment of uterine leiomyomas (fibroids)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H1556819081\"><span class=\"h3\">Uterine diverticulum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A case report described severe vaginal bleeding on the 47<sup>th</sup> day after a cesarean delivery [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/15\" class=\"abstract_t\">15</a>]. Transvaginal ultrasound examination, which showed a thickened heteroechoic endometrium with an isolated isthmic heteroechoic cystic lesion, was not diagnostic and curettage did not control bleeding. Because of severe bleeding, emergency laparotomy was performed and the diagnosis of a diverticulum in the lateral wall of the uterine isthmus was made. Obliteration of the diverticulum by sutures controlled the hemorrhage.</p><p class=\"headingAnchor\" id=\"H66619989\"><span class=\"h3\">Hypoestrogenism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If a hypoestrogenic state is identified, the aim is to stimulate rapid endometrial growth with estrogen as long as there are no contraindications to hormonal therapy. The choice of whether to administer estrogen orally or intravenously should be based on severity of bleeding and hemodynamic status.</p><p>One option would be to use intravenous conjugated equine estrogen (20 to 40 mg) every four hours (not to exceed a total dose of 300 mg). Once the bleeding is controlled, add 5 mg <a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a> orally, administer one final dose of estrogen intravenously, and begin an estrogen-progestin contraceptive pill with 35 mcg ethinyl estradiol twice a day for 4 to 5 days, tapering to one pill daily. Alternatively, instead of initiating intravenous conjugated equine estrogen, an oral contraceptive pill with 35 mcg ethinyl estradiol is administered every six hours until the bleeding is controlled, then tapered on consecutive days to 35 mcg every eight hours, every 12 hours, and then daily.</p><p class=\"headingAnchor\" id=\"H1900246502\"><span class=\"h1\">SPECIAL POPULATIONS</span></p><p class=\"headingAnchor\" id=\"H1997226072\"><span class=\"h2\">Severe PPH outside of the hospital setting</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If PPH is severe and does not occur while the patient is hospitalized, emergency responders can administer <a href=\"topic.htm?path=tranexamic-acid-drug-information\" class=\"drug drug_general\">tranexamic acid</a> and rapidly transport the patient to a hospital where diagnostic evaluation and definitive therapy can be performed. In those desperate cases in which the patient is critically unstable, the use of an anti-shock garment may be helpful for reversing hypovolemic shock and decreasing obstetric hemorrhage while the patient is being transported [<a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/41-43\" class=\"abstract_t\">41-43</a>].</p><p class=\"headingAnchor\" id=\"H3375864337\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary or late postpartum PPH is generally defined as any significant uterine bleeding occurring between 24 hours and 12 weeks postpartum. (See <a href=\"#H1030069322\" class=\"local\">'Definition/diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common causes of secondary PPH are retained products of conception, subinvolution of the placental bed, <span class=\"nowrap\">and/or</span> infection. (See <a href=\"#H1888908394\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rare causes of secondary PPH include (see <a href=\"#H1888908394\" class=\"local\">'Etiology'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Inherited or acquired bleeding diatheses</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Pseudoaneurysm of the uterine artery</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Arteriovenous malformations</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Choriocarcinoma</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Undiagnosed carcinoma of the cervix</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Adenomyosis</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Infected polyp or submucosal fibroid</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Uterine diverticulum</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Excessive bleeding with resumption of menses</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hypoestrogenism</p><p/><p class=\"bulletIndent1\">Sometimes the cause cannot be determined.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the patient is hemodynamically unstable, stabilization is the priority, followed by diagnostic evaluation (<a href=\"image.htm?imageKey=OBGYN%2F101276\" class=\"graphic graphic_algorithm graphicRef101276 \">algorithm 1</a>). Such patients should be evaluated in a venue suitable for surgical intervention until sufficiently stable for transfer to a lower acuity setting. In women experiencing secondary PPH in the first few weeks after delivery, the uterine cavity may be large enough to admit a balloon tamponade device, which may be useful to limit bleeding while diagnostic evaluation occurs.(See <a href=\"#H329570042\" class=\"local\">'Stabilization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Management is guided by the cause of bleeding (<a href=\"image.htm?imageKey=OBGYN%2F101276\" class=\"graphic graphic_algorithm graphicRef101276 \">algorithm 1</a>). (See <a href=\"#H2373948967\" class=\"local\">'Management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Surgical procedures (dilation and curettage, suction curettage) are often effective when medical management fails, even if retained placental or membrane fragments cannot be identified sonographically. Arterial embolization is another option. (See <a href=\"#H647402319\" class=\"local\">'Subinvolution of the placental site'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/1\" class=\"nounderline abstract_t\">Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol 2017; 130:e168.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/2\" class=\"nounderline abstract_t\">Dossou M, Debost-Legrand A, D&eacute;chelotte P, et al. Severe secondary postpartum hemorrhage: a historical cohort. Birth 2015; 42:149.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/3\" class=\"nounderline abstract_t\">Alexander J, Thomas P, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database Syst Rev 2002; :CD002867.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/4\" class=\"nounderline abstract_t\">Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG 2001; 108:927.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/5\" class=\"nounderline abstract_t\">Marshall AL, Durani U, Bartley A, et al. The impact of postpartum hemorrhage on hospital length of&nbsp;stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol 2017; 217:344.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/6\" class=\"nounderline abstract_t\">Nanjundan P, Rohilla M, Raveendran A, et al. Pseudoaneurysm of uterine artery: a rare cause of secondary postpartum hemorrhage, managed with uterine artery embolisation. J Clin Imaging Sci 2011; 1:14.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/7\" class=\"nounderline abstract_t\">Yun SY, Lee DH, Cho KH, et al. Delayed postpartum hemorrhage resulting from uterine artery pseudoaneurysm rupture. J Emerg Med 2012; 42:e11.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/8\" class=\"nounderline abstract_t\">Hayata E, Matsuda H, Furuya K. Rare case of postpartum hemorrhage caused by rupture of a uterine artery pseudoaneurysm 3 months after Cesarean delivery. Ultrasound Obstet Gynecol 2010; 35:621.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/9\" class=\"nounderline abstract_t\">Marnela K, Saarelainen S, Palom&auml;ki O, Kirkinen P. Sonographic diagnosis of postpartum pseudoaneurysms of the uterine artery: a report of 2 cases. J Clin Ultrasound 2010; 38:205.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/10\" class=\"nounderline abstract_t\">Lausman AY, Ellis CA, Beecroft JR, et al. A rare etiology of delayed postpartum hemorrhage. J Obstet Gynaecol Can 2008; 30:239.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/11\" class=\"nounderline abstract_t\">Aziz N, Lenzi TA, Jeffrey RB Jr, Lyell DJ. Postpartum uterine arteriovenous fistula. Obstet Gynecol 2004; 103:1076.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/12\" class=\"nounderline abstract_t\">Yi SW, Ahn JH. Secondary postpartum hemorrhage due to a pseudoaneurysm rupture at the fundal area of the uterus: a case treated with selective uterine arterial embolization. Fertil Steril 2010; 93:2048.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/13\" class=\"nounderline abstract_t\">G&uuml;rses C, Yilmaz S, Biyikli S, et al. Uterine artery pseudoaneurysm: unusual cause of delayed postpartum hemorrhage. J Clin Ultrasound 2008; 36:189.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/14\" class=\"nounderline abstract_t\">Wang PH, Pang YP, Chao HT, et al. Delayed postpartum hemorrhage in adenomyosis: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61:492.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/15\" class=\"nounderline abstract_t\">Wu MC, Hsu YP, Lin HH, Hsiao SM. Severe delayed postpartum hemorrhage due to a neglected uterine diverticulum: a case report. J Reprod Med 2013; 58:347.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/16\" class=\"nounderline abstract_t\">Zubor P, Kajo K, Dokus K, et al. Recurrent secondary postpartum hemorrhages due to placental site vessel subinvolution and local uterine tissue coagulopathy. BMC Pregnancy Childbirth 2014; 14:80.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/17\" class=\"nounderline abstract_t\">Dewhurst CJ. Secondary post-partum haemorrhage. J Obstet Gynaecol Br Commonw 1966; 73:53.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/18\" class=\"nounderline abstract_t\">Thorsteinsson VT, Kempers RD. Delayed postpartum bleeding. Am J Obstet Gynecol 1970; 107:565.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/19\" class=\"nounderline abstract_t\">Marchant S, Alexander J, Thomas P, et al. Risk factors for hospital admission related to excessive and/or prolonged postpartum vaginal blood loss after the first 24 h following childbirth. Paediatr Perinat Epidemiol 2006; 20:392.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/20\" class=\"nounderline abstract_t\">Debost-Legrand A, Rivi&egrave;re O, Dossou M, Vendittelli F. Risk Factors for Severe Secondary Postpartum Hemorrhages: A Historical Cohort Study. Birth 2015; 42:235.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/21\" class=\"nounderline abstract_t\">Govorov I, L&ouml;fgren S, Chaireti R, et al. Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study. PLoS One 2016; 11:e0164683.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/22\" class=\"nounderline abstract_t\">Mulic-Lutvica A, Axelsson O. Ultrasound finding of an echogenic mass in women with secondary postpartum hemorrhage is associated with retained placental tissue. Ultrasound Obstet Gynecol 2006; 28:312.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/23\" class=\"nounderline abstract_t\">Mulic-Lutvica A, Eurenius K, Axelsson O. Uterine artery Doppler ultrasound in postpartum women with retained placental tissue. Acta Obstet Gynecol Scand 2009; 88:724.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/24\" class=\"nounderline abstract_t\">Petrovitch I, Beatty M, Jeffrey RB, Heerema-McKenney A. Subinvolution of the placental site. J Ultrasound Med 2009; 28:1115.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/25\" class=\"nounderline abstract_t\">Timmerman D, Wauters J, Van Calenbergh S, et al. Color Doppler imaging is a valuable tool for the diagnosis and management of uterine vascular malformations. Ultrasound Obstet Gynecol 2003; 21:570.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/26\" class=\"nounderline abstract_t\">Feigenberg T, Eitan Y, Sela HY, et al. Surgical versus medical treatment for secondary post-partum hemorrhage. Acta Obstet Gynecol Scand 2009; 88:909.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/27\" class=\"nounderline abstract_t\">King PA, Duthie SJ, Dong ZG, Ma HK. Secondary postpartum haemorrhage. Aust N Z J Obstet Gynaecol 1989; 29:394.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/28\" class=\"nounderline abstract_t\">OBER WB, GRADY HG. Subinvolution of the placental site. Bull N Y Acad Med 1961; 37:713.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/29\" class=\"nounderline abstract_t\">Kavalar R, Arko D, Fokter Dovnik N, Taka&#269; I. Subinvolution of placental bed vessels: case report and review of the literature. Wien Klin Wochenschr 2012; 124:725.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/30\" class=\"nounderline abstract_t\">Pelage JP, Soyer P, Repiquet D, et al. Secondary postpartum hemorrhage: treatment with selective arterial embolization. Radiology 1999; 212:385.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/31\" class=\"nounderline abstract_t\">Park HS, Shin JH, Yoon HK, et al. Transcatheter arterial embolization for secondary postpartum hemorrhage: outcome in 52 patients at a single tertiary referral center. J Vasc Interv Radiol 2014; 25:1751.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/32\" class=\"nounderline abstract_t\">Hollier LM, Scott LL, Murphree SS, Wendel GD Jr. Postpartum endometritis caused by herpes simplex virus. Obstet Gynecol 1997; 89:836.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/33\" class=\"nounderline abstract_t\">R&oslash;rbye C, Petersen IS, Nilas L. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome. Acta Obstet Gynecol Scand 2000; 79:1134.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/34\" class=\"nounderline abstract_t\">Bitti A, Mastrantonio P, Spigaglia P, et al. A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol 1997; 50:259.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/35\" class=\"nounderline abstract_t\">Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/36\" class=\"nounderline abstract_t\">Cohen AL, Bhatnagar J, Reagan S, et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol 2007; 110:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/37\" class=\"nounderline abstract_t\">Jorup-R&ouml;nstr&ouml;m C, Hofling M, Lundberg C, Holm S. Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature. Infection 1996; 24:164.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/38\" class=\"nounderline abstract_t\">Gibney RT, Moore A, Muldowney FP. Toxic-shock syndrome associated with post-partum staphylococcal endometritis. Ir Med J 1983; 76:90.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/39\" class=\"nounderline abstract_t\">Gibbs RS, Blanco JD. Streptococcal infections in pregnancy. A study of 48 bacteremias. Am J Obstet Gynecol 1981; 140:405.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/40\" class=\"nounderline abstract_t\">Plunk M, Lee JH, Kani K, Dighe M. Imaging of postpartum complications: a multimodality review. AJR Am J Roentgenol 2013; 200:W143.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/41\" class=\"nounderline abstract_t\">Turan J, Ojengbede O, Fathalla M, et al. Positive effects of the non-pneumatic anti-shock garment on delays in accessing care for postpartum and postabortion hemorrhage in Egypt and Nigeria. J Womens Health (Larchmt) 2011; 20:91.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/42\" class=\"nounderline abstract_t\">Miller S, Martin HB, Morris JL. Anti-shock garment in postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22:1057.</a></li><li><a href=\"https://www.uptodate.com/contents/secondary-late-postpartum-hemorrhage/abstract/43\" class=\"nounderline abstract_t\">Sutherland T, Downing J, Miller S, et al. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One 2013; 8:e62282.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 113133 Version 7.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H3375864337\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H908497887\" id=\"outline-link-H908497887\">INTRODUCTION</a></li><li><a href=\"#H1030069322\" id=\"outline-link-H1030069322\">DEFINITION/DIAGNOSIS</a></li><li><a href=\"#H3833543019\" id=\"outline-link-H3833543019\">INCIDENCE</a></li><li><a href=\"#H1888908394\" id=\"outline-link-H1888908394\">ETIOLOGY</a></li><li><a href=\"#H3270025581\" id=\"outline-link-H3270025581\">RISK FACTORS</a></li><li><a href=\"#H3152310892\" id=\"outline-link-H3152310892\">CLINICAL PRESENTATION</a></li><li><a href=\"#H329570042\" id=\"outline-link-H329570042\">STABILIZATION</a></li><li><a href=\"#H1803423708\" id=\"outline-link-H1803423708\">DIAGNOSTIC EVALUATION</a><ul><li><a href=\"#H1067536136\" id=\"outline-link-H1067536136\">History and physical examination</a></li><li><a href=\"#H2114630160\" id=\"outline-link-H2114630160\">Imaging</a><ul><li><a href=\"#H299044673\" id=\"outline-link-H299044673\">- Findings</a><ul><li><a href=\"#H63300053\" id=\"outline-link-H63300053\">Endometritis and intrauterine infection</a></li><li><a href=\"#H4267008826\" id=\"outline-link-H4267008826\">Retained products of conception</a></li><li><a href=\"#H2144156391\" id=\"outline-link-H2144156391\">Subinvolution of the placental site</a></li><li><a href=\"#H2834089873\" id=\"outline-link-H2834089873\">Bleeding diathesis</a></li><li><a href=\"#H2786060684\" id=\"outline-link-H2786060684\">Vascular malformations</a></li><li><a href=\"#H280235462\" id=\"outline-link-H280235462\">Hypoestrogenism</a></li></ul></li></ul></li><li><a href=\"#H1611553929\" id=\"outline-link-H1611553929\">Laboratory tests</a></li><li><a href=\"#H3751209655\" id=\"outline-link-H3751209655\">Selective testing</a></li></ul></li><li><a href=\"#H2373948967\" id=\"outline-link-H2373948967\">MANAGEMENT</a><ul><li><a href=\"#H4066198572\" id=\"outline-link-H4066198572\">Management of common causes of secondary PPH</a><ul><li><a href=\"#H3495049404\" id=\"outline-link-H3495049404\">- Initial approach</a></li><li><a href=\"#H1335192041\" id=\"outline-link-H1335192041\">- Retained products of conception</a></li><li><a href=\"#H647402319\" id=\"outline-link-H647402319\">- Subinvolution of the placental site</a></li><li><a href=\"#H2527119692\" id=\"outline-link-H2527119692\">- Endometritis</a></li></ul></li><li><a href=\"#H929780837\" id=\"outline-link-H929780837\">Management of uncommon and rare causes of secondary PPH</a><ul><li><a href=\"#H2786981985\" id=\"outline-link-H2786981985\">- Vascular lesions</a></li><li><a href=\"#H370424034\" id=\"outline-link-H370424034\">- Bleeding diathesis</a></li><li><a href=\"#H3225548484\" id=\"outline-link-H3225548484\">- Neoplasia</a></li><li><a href=\"#H1556819081\" id=\"outline-link-H1556819081\">- Uterine diverticulum</a></li><li><a href=\"#H66619989\" id=\"outline-link-H66619989\">- Hypoestrogenism</a></li></ul></li></ul></li><li><a href=\"#H1900246502\" id=\"outline-link-H1900246502\">SPECIAL POPULATIONS</a><ul><li><a href=\"#H1997226072\" id=\"outline-link-H1997226072\">Severe PPH outside of the hospital setting</a></li></ul></li><li><a href=\"#H3375864337\" id=\"outline-link-H3375864337\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"OBGYN/113133|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/101276\" class=\"graphic graphic_algorithm\">- Diagnosis and management of secondary PPH</a></li></ul></li><li><div id=\"OBGYN/113133|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/73717\" class=\"graphic graphic_diagnosticimage\">- Fluid and debris in postpartum uterus</a></li><li><a href=\"image.htm?imageKey=OBGYN/101346\" class=\"graphic graphic_diagnosticimage\">- Postpartum endometritis associated with bleeding</a></li><li><a href=\"image.htm?imageKey=OBGYN/101344\" class=\"graphic graphic_diagnosticimage\">- Retained products of conception causing secondary PPH</a></li><li><a href=\"image.htm?imageKey=OBGYN/101347\" class=\"graphic graphic_diagnosticimage\">- Vascularized retained products of conception with secondary PPH</a></li><li><a href=\"image.htm?imageKey=OBGYN/101345\" class=\"graphic graphic_diagnosticimage\">- Blood clot in postpartum uterus</a></li><li><a href=\"image.htm?imageKey=OBGYN/75900\" class=\"graphic graphic_diagnosticimage\">- U-S choriocarcinoma</a></li><li><a href=\"image.htm?imageKey=OBGYN/52443\" class=\"graphic graphic_diagnosticimage\">- Doppler U-S choriocarcinoma</a></li></ul></li><li><div id=\"OBGYN/113133|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/64669\" class=\"graphic graphic_table\">- Antibiotic regimens endometritis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis\" class=\"medical medical_review\">Approach to the adult patient with a bleeding diathesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endometrial-polyps\" class=\"medical medical_review\">Endometrial polyps</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gestational-trophoblastic-neoplasia-epidemiology-clinical-features-diagnosis-staging-and-risk-stratification\" class=\"medical medical_review\">Gestational trophoblastic neoplasia: Epidemiology, clinical features, diagnosis, staging, and risk stratification</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intrauterine-adhesions-clinical-manifestation-and-diagnosis\" class=\"medical medical_review\">Intrauterine adhesions: Clinical manifestation and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=invasive-cervical-cancer-epidemiology-risk-factors-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-early-stage-cervical-cancer\" class=\"medical medical_review\">Management of early-stage cervical cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">Overview of postpartum hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-postpartum-period-physiology-complications-and-maternal-care\" class=\"medical medical_review\">Overview of the postpartum period: Physiology, complications, and maternal care</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-treatment-of-uterine-leiomyomas-fibroids\" class=\"medical medical_review\">Overview of treatment of uterine leiomyomas (fibroids)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postpartum-endometritis\" class=\"medical medical_review\">Postpartum endometritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postpartum-hemorrhage-management-approaches-requiring-laparotomy\" class=\"medical medical_review\">Postpartum hemorrhage: Management approaches requiring laparotomy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postpartum-hemorrhage-medical-and-minimally-invasive-management\" class=\"medical medical_review\">Postpartum hemorrhage: Medical and minimally invasive management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uterine-adenomyosis\" class=\"medical medical_review\">Uterine adenomyosis</a></li></ul></div></div>","javascript":null}